Related Experiment Video

Updated: Aug 22, 2025

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

14.1K

Reply: Is Pathology Always the Diagnostic Gold Standard in Neurodegeneration?

Stephen A Ryan1,2, Mario Masellis1,3, Juan Bilbao4

  • 1L.C. Campbell Cognitive Neurology Research Unit Sunnybrook Health Sciences Centre Toronto Ontario Canada.

Movement Disorders Clinical Practice
|November 7, 2022
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

17.5K
Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
08:33

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

Published on: June 25, 2019

8.3K

Related Experiment Videos

Last Updated: Aug 22, 2025

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

14.1K
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

17.5K
Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
08:33

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

Published on: June 25, 2019

8.3K

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

625
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
625
Neural Regulation01:37

Neural Regulation

39.7K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.7K

Articles linked to this work by shared authors, journal, and citation graph.

The Interaction Between Neuroinflammation and β-Amyloid in Cognitive Decline in Parkinson's Disease.

Molecular neurobiology·2019

Tongue Protrusion Dystonia in Pantothenate Kinase-Associated Neurodegeneration.

Pediatric neurology·2019

The clinical significance of lower limb tremors.

Parkinsonism & related disorders·2019

Parkinson's disease in the Western Pacific Region.

The Lancet. Neurology·2019

Hiding in Plain Sight: Functional Neurological Disorders in the News.

The Journal of neuropsychiatry and clinical neurosciences·2019

Dystonia and Parkinson's disease: What is the relationship?

Neurobiology of disease·2019

Preoperative Glymphatic Asymmetry Is Associated with Motor Outcomes Following STN-DBS in Parkinson's Disease.

Movement disorders clinical practice·2026

Lower Urinary Tract Symptoms as Diagnostic Clues in Parkinsonism: A Practical Framework for Neurologists.

Movement disorders clinical practice·2026

Clinically Probable REM Sleep Behavior Disorder and Other Non-Motor Symptoms in Progressive Supranuclear Palsy: Prevalence and Associated Clinical Features.

Movement disorders clinical practice·2026

Interrater and Intrarater Reliability of the TWSTRS-Delphi Motor Severity Scale for Cervical Dystonia.

Movement disorders clinical practice·2026

How Do Oral Medications, Botulinum Toxin Use, and Treatment Burden Change after Deep Brain Stimulation for Dystonia?

Movement disorders clinical practice·2026

Breathe, Eat, Talk: Three Essential Ingredients to Quality-of-Life Outcomes in Movement Disorders.

Movement disorders clinical practice·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us